CompoAtlas

LINFONORM

Food supplement declared in France, declaration No 2016-6-739, decision dated 22 June 2016

LINFONORM (TERALI) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
TERALI
Food business operator placing the product on the market
TERALI
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Capsule
Daily dose
2 Caspules par jour
Directions for use
avec un grand verre d’eau après les repas
Not recommended for (according to the manufacturer)
Allergie aux dérivés salicylés, Enfants (moins de 12 ans), Sous anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Artères et cholestérol, Détoxifiant / Draineur, Circulation sanguine et lymphatique

Declaration 274587, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Betula pendula RothFeuilleExtrait sec hydroalcoolique200 mg
Sedum roseum (L.) Scop.RacineExtrait sec hydroalcoolique200 mg

Other active ingredients

NamePer day
Serrapeptasenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Gluconate de cuivreCuivre5,000 µg2,000 µg
Sulfate de zincZinc25 mg15 mg

Additives

E341, E551, E131, E132, E470b

Other ingredients

gélatine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2016. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

L'emploi est déconseillé aux personnes souffrant d'allergie aux dérivés salicylés et chez les personnes sous traitement anti-coagulant et chez les enfants de moins de 12 ans.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : TERALI

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line